Seed round
CurifyLabs
CEO: Charlotta Topelius
Founders: Charlotta Topelius, Niklas Sandler Topelius
Founders: Charlotta Topelius, Niklas Sandler Topelius
We are a sector agnostic early-stage investor that wants to partner with founders from the very beginning of their journey and support them throughout their growth. Our team has global experience in building and scaling companies both as founders and in various CxO roles. We invest in ambitious and determined teams that can one day become industry leaders.
New investments
Charlotta Topelius and Niklas Sandler Topelius
Seed round
Hyperion Robotics
CEO: Fernando De los Rios
Founders: Fernando De los Rios, Ashish Mohite, Henry Unterreiner
Founders: Fernando De los Rios, Ashish Mohite, Henry Unterreiner
Angel round
Focal
CEO: Tuomo Riekki
Founders: Tuomo Riekki, Andreas Stenman
Founders: Tuomo Riekki, Andreas Stenman
Seed round
Droppe
CEO: Johannes Salmisaari
Founders: Johannes Salmisaari, Henrik Helenius
Founders: Johannes Salmisaari, Henrik Helenius
Series A
Mobal
CEO: Jakob Wikström
Founders: Jakob Wikström & Alexander Silén
Founders: Jakob Wikström & Alexander Silén
Seed round
P2X Solutions
CEO: Herkko Plit
Founders: Herkko Plit, Jukka Juola
Founders: Herkko Plit, Jukka Juola
Seed round
Mjuk
CEO: Rickard Zilliacus
Founders: Rickard Zilliacus, Max Heino, Casper von Pfaler
Founders: Rickard Zilliacus, Max Heino, Casper von Pfaler
Pre-seed round
Measurlabs
CEO: Teemu Myllymäki
Founders: Teemu Myllymäki, Kalle Lagerblom
Founders: Teemu Myllymäki, Kalle Lagerblom
Angel round
Flowrite
CEO: Aaro Isosaari
Founders: Aaro Isosaari, Karolus Sariola
Founders: Aaro Isosaari, Karolus Sariola
Portfolio events
Charlotta Topelius and Niklas Sandler Topelius
Lifeline Ventures
Seed round
CurifyLabs
Through modernizing the drug compounding process in pharmacies, CurifyLabs enables sustainable, on-demand manufacture of medicines, customized to provide safe and effective treatment for all patients.
Read moreCurifyLabs
Through modernizing the drug compounding process in pharmacies, CurifyLabs enables sustainable, on-demand manufacture of medicines, customized to provide safe and effective treatment for all patients. CurifyLabs is committed to automating and streamlining the drug compounding process enabling personalization of drug treatments to better fit the need of each specific patient. Our goal is to maximize the personalization potential of drug treatments for better patient outcomes with our pharmaceutical 3D printing concept. The technology is based on over 10 years of extensive academic research conducted by Professor Niklas Sandler Topelius and his research group. Today CurifyLabs serves pharmacies on several European markets with a talented team of pharmaceutical formulation developers, software engineers and quality control experts.
CEO: Charlotta Topelius
Founders: Charlotta Topelius, Niklas Sandler Topelius
2021
Founded
2022
Lifeline Ventures
Seed round
6/2022
Fernando De los Rios
Ashish Mohite
Henry Unterreiner
Seed round
Hyperion Robotics
Transforming the construction industry with large-scale 3D printing and low-carbon concrete.
Read moreHyperion Robotics
Hyperion is transforming the way concrete structures are built with their 3D printing Micro-factories and low-carbon concrete made from industrial waste streams. The company works with industrial, infrastructure and building clients and helps them digitally design and robotically manufacture concrete structures without moulds with less materials and less cement, reducing project times, costs, health and safety risks and CO2 emissions.
CEO: Fernando De los Rios
Founders: Fernando De los Rios, Ashish Mohite, Henry Unterreiner
2019
Founded
2022
Lifeline Ventures
Seed round
6/2022
Oskari Saarenmaa
Hannu Valtonen
Heikki Nousiainen
Mika Eloranta
Series C
Led by Atomico
Aiven
Aiven has raised $100 million in its Series C, bringing the company’s total investment to $150 million. Aiven will use the proceeds from the round to bring new products to market, increase contributions to developing open source technologies and continue the company’s international expansion.
Read moreAiven
Aiven provides fully managed cloud database and messaging services hosted in the cloud of the customer’s choice, including Amazon Web Services, Google Cloud Platform, and Microsoft Azure. Its mission is to allow developers to focus on building awesome applications without worrying about data infrastructure management.
CEO: Oskari Saarenmaa
Founders: Oskari Saarenmaa, Heikki Nousiainen, Mika Eloranta, Hannu Valtonen
2016
Founded
2017
Lifeline Ventures
Seed round
2019
Series A
Led by Earlybird
2020
Series B
Led by IVP
2021
Series C
Led by Atomico
05/2022
Niko Eiden
Klaus Melakari
Urho Konttori
Roope Rainisto
Series C
From Tesi, Lifeline Ventures, NordicNinja and Swisscanto
Varjo
Varjo, the leader in industrial-grade VR/XR hardware and software, has closed a $54 million round of Series C funding. The latest infusion of capital will allow Varjo to accelerate its global expansion and development of industry-leading hardware and software products.
Read moreVarjo
Varjo was founded by a team of industry professionals with decades of experience and a vision of seamlessly merging the virtual and real worlds. The Bionic Display™ in Varjo’s VR devices delivers an unprecedented human-eye resolution of 60 pixels per degree. It revolutionizes professional VR by bringing every detail, texture, contour and color into 20/20 focus.
CEO: Timo Toikkanen
Founders: Urho Konttori, Klaus Melakari, Roope Rainisto, Niko Eiden
2016
Founded
2016
Lifeline Ventures
Seed round
2017
Series A
Led by EQT Ventures
2018
Series B
Led by Atomico
2020
Series C
From Tesi, Lifeline Ventures, NordicNinja and Swisscanto
2022
Series D
From Tesi, Lifeline Ventures, Volvo Car Technology, Fefsi, Swisscanto and others
04/2022